(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. ... on its European commercial launch of MuGard, an FDA ... of radiation treatment and chemotherapy. MuGard is commercially launched ... the UK, Germany, Italy, Norway, Greece and Sweden. Access ...
(Date:12/3/2009)... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... its Series B Convertible Perpetual Preferred Stock ( IMA-PB). The ... in an amount per share equal to the quotient of ...
(Date:12/2/2009)... 2 Spectrum Blue Steel is emerging as one of ... the efforts of True Green Energy Group and True Green ... in the recycling business for over 25 years, stated that ... is setting the stage for spectacular earnings because of the ...
(Date:12/2/2009)... Nearly 600 medical research executives, scientists, policy makers, ... and innovative funding strategies at the inaugural Partnering ... the Washington-based center of the Milken Institute, convened ... to turn a scientific discovery into an accessible therapy. ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2... SAN DIEGO, June 18 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced that it ... to be held in New York on June ... and Chief Executive Officer,will present on Wednesday, June ...
... June 18 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX:,MS), a ... today,announced that Mr. Kevin Giese, President and CEO, will ... York., WHEN: Wednesday June 25th ... New York, About the Jefferies 2nd Annual Healthcare ...
... BCRX ) today announced that William P. ... of BioCryst, effective July 1,2008. Dr. Sheridan is ... President of North American Medical Affairs at Amgen, ... Simon, who has been with,the Company since January ...
Other Biology Technology:Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference 2BioMS Medical to present at Jefferies Healthcare Conference 2William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 2William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 3William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 4... Services include subcloning of gene ... insect cells, isolation and plaque purification ... high-titer virus stock for one clone, ... 1L insect cell culture. Expected yield ...
EDTA, tetrasodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99-101% (as is).Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemicals, Ul...
...
Request Info...
Biology Products: